Different Dutch and Belgian stakeholders from the industry and local health authorities (College ter Beoordeling van Geneesmiddelen and FAMHP – Federal Agency for Medicines and Health Products) shared their point of view on the feasibility to use common product information in BE and NL.
High level take aways shared by RA Director Wim Neckebroeck at AxTalis :
=> Implementation for centralized procedure products : 𝐠𝐨 𝐟𝐨𝐫 𝐢𝐭!
=> Implementation for national procedure products : 𝐟𝐨𝐫𝐠𝐞𝐭 𝐚𝐛𝐨𝐮𝐭 𝐢𝐭!
=> Implementation for mutual recognition and decentralized procedure products : 𝐥𝐞𝐭’𝐬 𝐝𝐢𝐬𝐜𝐮𝐬𝐬 𝐚𝐛𝐨𝐮𝐭 𝐢𝐭!
Do you want to know more about the implementation for CP products and the hurdles for MRP/DCP products?
Feel free to contact Wim Neckebroeck directly for any support needed.
